The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; 28 of the 37 sources its claims cite were checked for support.
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes
Open accessAbstract
Microglia are essential for CNS homeostasis and innate neuroimmune function, and play important roles in neurodegeneration and brain aging. Here we present gene expression profiles of purified microglia isolated at autopsy from the parietal cortex of 39 human subjects with intact cognition. Overall, genes expressed by human microglia were similar to those in mouse, including established microglial genes CX3CR1, P2RY12 and ITGAM (CD11B). However, a number of immune genes, not identified as part of the mouse microglial signature, were abundantly expressed in human microglia, including TLR, Fcγ and SIGLEC receptors, as well as TAL1 and IFI16, regulators of proliferation and cell cycle. Age-associated changes in human microglia were enriched for genes involved in cell adhesion, axonal guidance, cell surface receptor expression and actin (dis)assembly. Limited overlap was observed in microglial genes regulated during aging between mice and humans, indicating that human and mouse microglia age differently.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This study generated RNA-seq profiles of FACS-purified microglia from postmortem parietal cortex of 39 cognitively intact human donors and defined a 1,297-gene human microglial core signature. Human microglia broadly resembled mouse microglia but showed human-enriched immune genes and very limited overlap with mouse aging signatures, suggesting that human and mouse microglia age differently.
Key findings
- A human microglial core signature of 1,297 genes was defined by log fold change > 3 and adjusted P < 0.001 versus cortex; microglia expressed CX3CR1, P2RY12, ITGAM, and TYROBP at high levels, with extremely low/absent CCR2, and were enriched for immune genes including TLR, Fcγ, and SIGLEC receptors plus TAL1 and IFI16.
- Human microglia overlapped extensively with human CD45+ CNS cells (median Δ percentile 10.1) and with three mouse microglial datasets (median Δ percentiles 14.3, 20.4, and 9.3), but human-enriched genes included CD58, ERAP2, GNLY, and S100A12.
- With age (donors 34–102 years), 212 genes increased and 360 genes decreased in expression (P < 0.05); the top 100 genes most affected (P < 0.01) separated younger and older samples. Reduced genes included actin cytoskeleton genes TLN1, PFN1, EVL, ARPC1A, ARPC1B, CORO1A, CAP1, CTNNA2, and VASP; sensome receptors P2RY12, IL6R, and TLR10; and adhesion/guidance genes ICAM3, ROBO2, SEMA3C, and SEMA7A. Increased genes included DOCK1, DOCK5, CXCR4, CD163, IGF2R, VEGFA, and RUNX3.
- Human–mouse aging overlap was limited: 14 increased genes overlapped, including CXCR4, VEGFA, TNFAIP2, and GP2, and 9 decreased genes overlapped, including ETS1, SEMA7A, MRC2, PSTPIP1, and EMP2; about half of the shared aging genes showed opposite directionality between species.
Methods
- Microglia were acutely isolated by FACS from right parietal cortex autopsy tissue; 81 rapid isolations were performed (33 in the Netherlands, 48 in Brazil), and 39 high-quality RNA samples from donors with normal cognition and no apparent neuropathological abnormalities were RNA-sequenced, alongside 16 superior parietal cortex samples and 10 epilepsy surgery biopsies. Protein samples came from 7 donors.
- Paired-end Illumina HiSeq 2500 RNA-seq data were analyzed with limma, with batch/unwanted variation removed using sva; PCA assessed sample segregation, and differential expression used adjusted P < 0.001 and log(FC) > 3 for the microglial core signature. GO enrichment used GOstats, transcriptional regulators used CoRegNet, and protein interactions used STRING.
- Protein validation used western blotting, human hematopoietic antibody arrays on pooled FACS-sorted microglia, and immunohistochemistry/double immunofluorescence for IBA1, HLA-DR, CD32, CD36, LAG3, and TMEM119.
Limitations
- Stated: all donors suffered from pathologies ultimately leading to death, which may have affected microglial gene expression; human autopsy samples were compared with healthy mouse microglia; monocyte/macrophage comparisons may be partly confounded by batch effects; the sample was unbalanced by gender (7 females, 32 males), so more female donors would be needed to identify gender-specific traits; neuronal mRNAs in aged microglia might reflect phagocytosis during postmortem delay or age-related neuronal loss rather than intrinsic microglial expression.
- Evident: cross-species comparisons relied on different technologies and platforms (3′-end RNA sequencing, microarrays, RNA-seq) and small mouse sample sizes (n = 6, n = 4, n = 2 in the cited datasets), and the aging analyses are correlational, so they cannot establish causal effects of age on microglial function.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
28 of 37 cited sources checked · 13 supported · 1 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A recent publication indicated that the microglial population in the brain is replaced approximately every 100 d in both mice and humans 46 .”
What the sources say
- Partly supportedcites [46] Askew, K. et al. Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain. Cell Rep. 18, 391–405 (2017). sourceExperimental — accuracy not yet measured
The Results estimate renewal of the mouse microglial population every ∼96 days, and the Discussion gives ∼95 days. For humans, the Results estimate hundreds of renewal cycles over an 80-year lifetime, but the paper does not give a 100-day interval; the Discussion says a more accurate human turnover estimate needs alternative methods. (LLM, conf=0.88)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using CoRegNet, we identified regulators of the human core microglial genes.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and these transcription factors are abundantly expressed in the human microglial core.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When we analyzed the microglial expression data using PMD as a variable, we observed no effect.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Strikingly, we observed very little overlap between the human and mouse aging signatures.”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, we observed age-associated changes in genes involved in axonal guidance, cell adhesion and the sensome.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In comparison to monocytes, microglia were enriched for GO terms 'synapse organization,' 'neuron projection morphogenesis' 'cell projection morphogenesis' 'homophilic cell interactions' 'purine nucleotide metabolic process' and 'sphingolipid metabolic process' when compared to macrophages.”
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition to IRF8, human microglia expressed high levels of IRF1, IRF5 and IRF7.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As expected, many significantly enriched terms associated with the innate immune activity of microglia, such as 'immune response,' 'defense response' and 'cytokine production.'”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Gene ontology (GO) categories associated with the genes differentially expressed during aging ( Fig. 5b ) were enriched for CNS development, with associated changes categorized by GO terms such as 'cytoskeleton,' 'immune response' and 'motility (cell adhesion)' .”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: Age-associated gene expression changes in the donor microglia are attributable to aging rather than to cause of death, comorbidity or other donor characteristics.
- Probably not a substantial claim. 44
- It may state two separate claims as one. 28
- The quote only partly states this claim. 2
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“IFI16 is also involved in overcoming inhibitor of differentiation proteins (IDs) blocking of terminal cell differentiation 45 ,”
What the sources say
- Disputedcites [45] Luan, Y., Lengyel, P. & Liu, C.-J. p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation. Cytokine Growth Factor Rev. 19, 357–369 (2008). sourceExperimental — accuracy not yet measured
Section 3.2 attributes the ability to overcome Id-protein inhibition of differentiation to p204, not IFI16. The Summary and perspectives identifies IFI16 as a human protein structurally similar to p204, but does not assign p204’s Id-blocking activity to IFI16. The indexed passages provide no page numbers. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“While CIITA expression is restricted to antigen-presenting cells, NLRC5 is constitutively expressed in various tissues, most highly in cells from the hematopoietic lineage (CD4 + T cells, CD8 + T cells, CD19 + B cells, natural killer cells and natural killer T cells).”
What the sources say
- Could not verifycites [39] Meissner, T.B. et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. USA 107, 13794–13799 (2010). sourceExperimental — accuracy not yet measured
The Results describe experiments in Jurkat T cells and an epithelial cell line, but do not compare constitutive NLRC5 expression across tissues or hematopoietic cell types. Searches for CD19, hematopoietic expression, and tissue distribution found no passage establishing the claimed ranking or the listed cell types. (LLM, conf=0.76)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Overall, we observed an extensive overlap in gene expression between these data sets: the median ∆ percentile was 10.1, indicating most genes were similarly expressed in both data sets ( Fig. 2b ).”
What the sources say
- Could not verifycites [15] Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37–53 (2016). sourceExperimental — accuracy not yet measured
The Results section on acutely purified human brain cells reports microglial gene-expression markers, but not a comparison between a human microglial core and a published CD45+ population. The reported gene-expression overlap in the Results section on human and mouse astrocytes concerns different cell populations. Searches for CD45+ microglia and a median Δ percentile of 10.1 found no passage addressing the claim. (LLM, conf=0.73)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The published human CD45+ cell population from Zhang et al. is comparable to microglia for the overlap analysis.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Little is known about microglial gender differences, but a few studies have identified a gender-specific role for microglia in the rat brain 49 .”
What the sources say
- Supportedcites [49] Chen, Y., Won, S.J., Xu, Y. & Swanson, R.A. Targeting microglial activation in stroke therapy: pharmacological tools and gender effects. Curr. Med. Chem. 21, 2146–2155 (2014). source
The “Sexual Dimorphism in Stroke and Poststroke Inflammation” section reports sex differences in microglial activation after stroke and discusses rat ischemia models. The “Sexual Dimorphism in Response to Antiinflammatory Treatments” section says the few studies in this area point to large male–female differences; the References list a study of microglial activation in male but not female rats. The evidence concerns ischemia and its treatment, rather than every role of microglia in the rat brain. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“recent reports on the induction of human pluripotent stem cell-derived microglia-like cells demonstrated high levels of this transcription factor in such cells 40 .”
What the sources say
- Supportedcites [40] Muffat, J. et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22, 1358–1367 (2016). source
The Results section (‘pMGLs resemble primary human microglia, and differ from peripheral macrophages’) states that the derived microglia-like cells display high IRF8 expression. The Introduction identifies these cells as derived from human ES and iPS cells. (LLM, conf=0.94)
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“SIGLECs regulate the effects of activation, phagocytosis and inflammasome formation via their immunoreceptor tyrosine-based inhibition motif (ITIM) 37 .”
What the sources say
- Partly supportedcites [37] Macauley, M.S., Crocker, P.R. & Paulson, J.C. Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol. 14, 653–666 (2014). sourceExperimental — accuracy not yet measured
The introductory passage labelled Abstract says most Siglecs contain ITIMs and signal negatively, supporting a role in regulating activation. The 'Interactions of Siglecs with bacteria' section describes macrophage phagocytosis promoted by sialoadhesin, but explicitly says that receptor lacks intrinsic signaling motifs. No passage found supports regulation of inflammasome formation via ITIMs. (LLM, conf=0.87)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A quality check of aligned data was done with RNA-SEQC 55 and showed high quality alignment and data.”
What the sources say
- Supportedcites [55] DeLuca, D.S. et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 28, 1530–1532 (2012). source
The Abstract identifies RNA-SeQC as a program that provides data-quality measures, including alignment rates. The Metrics section says it accepts aligned BAM files and reports quality-control metrics. The statement that the citing authors' data were high quality is their own result, not a finding attributed to this source. (LLM, conf=0.91)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These receptors and their downstream signaling are implicated in chemotaxis and are part of the microglial sensome 4 .”
What the sources say
- Partly supportedcites [4] Hickman, S.E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896–1905 (2013). sourceExperimental — accuracy not yet measured
The Results section (Identification of the microglial Sensome by DRS; page unavailable) defines the sensome to include receptors and describes DAP12 as an adaptor that regulates signaling via TREM2. The Results section (Microglia vs. Macrophages; page unavailable) also identifies chemokine receptors among sensome genes. The copy does not link these receptors or their downstream signaling to chemotaxis. (LLM, conf=0.83)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“P2RY12, an established microglial marker 3,4 ,”
What the sources say
- Supportedcites [3] Butovsky, O. et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131–143 (2014). source
The Results section, “Identification of unique microglial surface molecules,” identifies P2ry12 as a unique microglial gene and reports that anti-P2ry12 stained resident microglia but not recruited monocytes, astrocytes, or neurons. This supports its use as a microglial marker. (LLM, conf=0.93)
- Supportedcites [4] Hickman, S.E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896–1905 (2013). source
The Results section on dual fluorescent in situ hybridization reports that P2ry12 mRNA co-localized with the microglial marker CD11b in young mouse brain: 98% of CD11b-expressing cells also expressed P2ry12, while CD11b-negative cells did not. The paper also identifies P2ry12 as a microglia-enriched sensome gene, supporting its use as a microglial marker. (LLM, conf=0.93)
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While CIITA expression is restricted to antigen-presenting cells, NLRC5 is constitutively expressed in various tissues, most highly in cells from the hematopoietic lineage (CD4 + T cells, CD8 + T cells, CD19 + B cells, natural killer cells and natural killer T cells).”
What the sources say
- Partly supportedcites [39] Meissner, T.B. et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. USA 107, 13794–13799 (2010). sourceExperimental — accuracy not yet measured
The paper’s opening section says CIITA expression is generally restricted to lymphocytes and professional antigen-presenting cells. The claim omits lymphocytes as a separate group and makes the restriction to antigen-presenting cells more absolute than the source does. (LLM, conf=0.88)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This is supported by observations in mice, where host microbiota control the maturation and function of microglia 33 .”
What the sources say
- Supportedcites [33] Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965–977 (2015). source
In “Defective microglia can be restored by a complex microbiota,” the paper states that microglia maturation and function are tightly controlled by the microbiota. The Introduction identifies germ-free and antibiotic-treated mice as the relevant observations, matching the citing sentence’s qualifier. (LLM, conf=0.95)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“NLRC5 expression levels are intermediate in monocytic CD14 + cells and CD11B + splenic myeloid cells.”
What the sources say
- Could not verifycites [39] Meissner, T.B. et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. USA 107, 13794–13799 (2010). sourceExperimental — accuracy not yet measured
The Results describe NLRC5 experiments in Jurkat T cells, HeLa cells, and HEK293T cells, but do not report its relative expression in CD14+ monocytes or CD11B+ splenic myeloid cells. Searches for CD14, CD11B, and intermediate expression in those cell types found no passage addressing the claim; page numbers were unavailable in our copy. (LLM, conf=0.72)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“PCA of our human microglial and published monocyte and macrophage data 30 indicated that these three data sets segregated and that microglia were the most distinct ( Supplementary Figure 1a ).”
What the sources say
- Supportedcites [30] Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345, 1251086 (2014). source
The citation identifies the published monocyte and macrophage data used in the citing authors’ PCA, not the PCA result itself. The source paper’s Methodology (Genome-wide epigenetic profiling) describes profiles for human monocytes and macrophages and gives their data accession, GSE58310. (LLM, conf=0.92)
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“An extensive overlap was observed between human and these three independent mouse microglial gene expression data sets ( Fig. 2c ). The median ∆ percentiles were 14.3, 20.4 and 9.3 for our own expression data set, that of Grabert et al. 23 and that of Matcovich-Natan et al. 24 , respectively.”
What the sources say
- Supportedcites [23] Grabert, K. et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19, 504–516 (2016). source
The citation identifies Grabert et al. as one of the mouse microglial gene-expression datasets used in the citing authors’ comparison. Grabert et al.’s Methods (Transcriptional profiling using gene expression microarrays; page unavailable) describe profiling RNA on whole-mouse-genome arrays. The overlap and median Δ percentiles are results reported by the citing authors, not attributed to Grabert et al. as findings of that paper. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [24] Matcovitch-Natan, O. et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science 353, aad8670 (2016). source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Cross-species comparisons using different RNA quantification technologies (3' QuantSeq, microarrays and RNA-seq) are valid for assessing overlap.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“IFI16 (p204) is associated with viral infection and the response to cytosolic double-stranded DNA 44 .”
What the sources say
- Supportedcites [44] Gürtler, C. & Bowie, A.G. Innate immune detection of microbial nucleic acids. Trends Microbiol. 21, 413–420 (2013). source
The ‘Role of PYHIN proteins in DNA sensing’ section identifies IFI16 and its apparent mouse functional ortholog p204 as DNA sensors. It reports that p204 knockdown inhibited responses to DNA and HSV-1 infection, and that IFI16 bound viral double-stranded DNA used to study cytosolic sensing. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“CD33 (SIGLEC3), a known microglial marker, is associated with the accumulation of amyloidβ plaques in mouse Alzheimer's disease models due to the diminished phagocytic capacity of microglial cells upregulating this gene 38 .”
What the sources say
- Partly supportedcites [38] Griciuc, A. et al. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631–643 (2013). sourceExperimental — accuracy not yet measured
The Results section, “CD33 Activity Promotes Amyloid Beta Pathology In Vivo” (page not provided), reports reduced plaque burden in APP/PS1 mice lacking CD33 and suggests that CD33-deficient microglia have greater Aβ clearance capacity. The paper also shows that higher CD33 levels impair microglial Aβ uptake in culture. It reports increased microglial CD33 expression in human AD brains, but does not show that microglia upregulate CD33 in the mouse models. (LLM, conf=0.85)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In monocytes, heterodimers between CXCR2 and CD74 or between CXCR4 and CD74 induce PI3K-AKT signaling and p53 inhibition, leading to increased survival, proliferation and apoptosis evasion 22 .”
What the sources say
- Partly supportedcites [22] Mitchell, R.A. et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99, 345–350 (2002). sourceExperimental — accuracy not yet measured
The Results and Discussion (page not provided) support MIF-mediated p53 inhibition and reduced apoptosis in mouse macrophages. They describe a Cox-2/PGE2 mechanism, not CXCR2–CD74 or CXCR4–CD74 heterodimers or PI3K–AKT signaling; they also do not establish increased monocyte proliferation. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“It regulates cell proliferation and transcription through different interactions with p53 and STAT3.”
What the sources say
- Could not verifycites [44] Gürtler, C. & Bowie, A.G. Innate immune detection of microbial nucleic acids. Trends Microbiol. 21, 413–420 (2013). sourceExperimental — accuracy not yet measured
The section “Role of PYHIN proteins in DNA sensing” (page unavailable) describes IFI16 as a DNA sensor involved in immune signaling and gene induction. Neither that section nor the additional passages retrieved for p53 and STAT3 address IFI16 regulating cell proliferation or transcription through interactions with those proteins. (LLM, conf=0.72)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“For instance, talin-1 (TLN1), a protein involved in actin remodeling and cell motility; profilin (PFN1), a protein directly involved in actin binding and polymerization; and VASP, a protein involved in actin filaments elongation, are less abundant in microglia isolated from older donors 47 .”
What the sources say
- Could not verifycites [47] Vincent, C., Siddiqui, T.A. & Schlichter, L.C. Podosomes in migrating microglia: components and matrix degradation. J. Neuroinflammation 9, 190 (2012). sourceExperimental — accuracy not yet measured
The Methods (Cells; page unavailable) describe microglia cultured from 1- to 2-day-old rat pups, not older donors. The Results identify talin in microglial podosomes, but the passages found when searching for PFN1, VASP, and age-related abundance do not report a comparison between younger and older donors. (LLM, conf=0.76)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chromatin immunoprecipitation and sequencing analysis previously indicated that TAL1 forms a complex with RUNX1 and LYL1 (ref. 42),”
What the sources say
- Partly supportedcites [42] Wilson, N.K. et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7, 532–544 (2010). sourceExperimental — accuracy not yet measured
The Results report ChIP-seq evidence that SCL/TAL1, LYL1, and RUNX1 bind in close proximity, suggesting cooperative binding. They also report coimmunoprecipitation evidence for a SCL–RUNX1 protein complex, but do not establish that LYL1 is part of that same complex. (LLM, conf=0.86)
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Sex differences in microglial function in the developing brain are associated with neurodevelopmental and psychiatric conditions 50 .”
What the sources say
- Supportedcites [50] Lenz, K.M. & McCarthy, M.M. A starring role for microglia in brain sex differences. Neuroscientist 21, 306–321 (2015). source
The Abstract says sex differences in microglia and neuroimmune signaling may contribute to sex differences in the incidence of neuropsychiatric and neurological disorders. In “Sex Differences in Neurodevelopmental Disorders” (page unavailable), the authors hypothesize that microglia and inflammatory molecules involved in normal brain sexual differentiation contribute to male vulnerability to disorders including autism. (LLM, conf=0.90)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“NLRC5 and CIITA are the respective master regulators of MHC class I and II gene expression 39 .”
What the sources say
- Partly supportedcites [39] Meissner, T.B. et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. USA 107, 13794–13799 (2010). sourceExperimental — accuracy not yet measured
The Discussion calls CIITA a master regulator of MHC class II expression. It finds NLRC5 necessary and sufficient for MHC class I induction in the experiments reported, but says only that NLRC5 may play a dominant role and may act as CIITA’s counterpart; its status as a master regulator is therefore overstated. Page numbers are not provided in the supplied passages. (LLM, conf=0.86)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Notably, microglial process motility directed toward site of damage was significantly impaired in mice with A β plaques 48 .”
What the sources say
- Supportedcites [48] Krabbe, G. et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 8, e60921 (2013). source
The Results section, “Directed Microglial Process Motility Towards Acute Tissue Lesion is Impaired in Transgenic AD Mice,” reports a markedly reduced response to laser-induced injury in Aβ plaque-bearing APPPS1 mice compared with controls. Figure 1 reports the lesion-directed movement difference as significant (p<0.05). (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“To minimize the reported effect of brain region on microglial gene expression 6,23,24 , only cortical microglia were included in our comparisons.”
What the sources say
- Could not verifycites [6] Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–11947 (2014). sourceExperimental — accuracy not yet measured
The citation is attached to the reported effect of brain region on microglial gene expression, not to the citing authors’ decision to include only cortical microglia. The Introduction and ‘Creation of an RNA-Seq transcriptome library’ describe profiling cells from mouse cortex, but do not report a comparison of microglial expression across brain regions. Searches for regional differences in microglial expression found no passage addressing that effect. (LLM, conf=0.76)
- Supportedcites [23] Grabert, K. et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19, 504–516 (2016). source
The Results section, “The microglial transcriptome is regionally heterogeneous” (page not supplied), reports that expression of 2,527 genes differed by brain region. This supports the attributed regional effect; including only cortical microglia was the citing authors’ own comparison choice, not a choice attributed to this source. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [24] Matcovitch-Natan, O. et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science 353, aad8670 (2016). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Unwanted or hidden sources of variation, such as the use of different library preps (Illumina and Takara) and different batches, were removed using the sva package 60 .”
What the sources say
- Supportedcites [60] Leek, J.T., Johnson, W.E., Parker, H.S., Jaffe, A.E. & Storey, J.D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882–883 (2012). source
The Introduction identifies sva as a package for removing batch effects and other unwanted variation in high-throughput experiments. Section 2.2 describes its method for adjusting for hidden variation. The citation identifies the tool used; the library preparations and batches describe the citing study, not a finding attributed to this source. (LLM, conf=0.91)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Genes with higher expression during aging included integrin modulators DOCK1 and DOCK5 , receptors CXCR4 , CD163 and IGF2R , growth factor VEGFA and transcription factor RUNX3 .”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Age-associated gene expression changes in the donor microglia are attributable to aging rather than to cause of death, comorbidity or other donor characteristics.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Noteworthy genes with reduced expression during aging included many actin cytoskeleton-associated genes such as TLN1 , PFN1 , EVL , ARPC1A , ARPC1B , CORO1A , CAP1 , CTNNA2 and VASP , sensome cell surface receptors P2RY12 , IL6R and TLR10 , and cell adhesion molecules and cell surface receptors ICAM3 , ROBO2 , SEMA3C and SEMA7A .”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Age-associated gene expression changes in the donor microglia are attributable to aging rather than to cause of death, comorbidity or other donor characteristics.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the small number of genes that were shared between human and microglia during aging, about half displayed opposite directionalities in expression during aging-for example, upregulated in mouse and downregulated in human or vice versa.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“while genes involved in cell cycle are also highly expressed.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, several human microglial genes were much less abundantly expressed in mouse microglia. Examples of human microgliaenriched genes are CD58, an adhesion molecule with a central role in the clustering of mature dendritic cells and T lymphocyte activation 25 .”
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“as exemplified by the downregulation of ID4 in microglia.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Microglial and cortical samples segregated cleanly and were highly similar within each tissue group, indicating that microglial expression profiles are very different from unsorted parietal cortex expression data ( Fig. 1b ).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Notably, although human microglia seem to possess a highly activated pathway for proliferation (the aforementioned CXCR-CD74 axis),”
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cells with highly ramified microglial morphology were detected with the indicated antibodies. Using double immunofluorescence staining, we observed extensive colocalization with established microglial markers IBA1 and HLA-DR.”
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Considerable overlap between human and mouse microglial gene expression was observed, but noteworthy dissimilarities were also present.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Cross-species comparisons using different RNA quantification technologies (3' QuantSeq, microarrays and RNA-seq) are valid for assessing overlap.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Written informed consent for research purposes was obtained and ethics committees from the School of Medicine of the University of São Paulo, Brazil, the Netherlands Brain Bank and the University Medical Center Groningen, the Netherlands approved the procedure.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In adults, TAL1 is expressed in hematopoietic cells but also in specific regions of the midbrain, hindbrain and spinal cord 41 .”
What the sources say
- Not checked — no full text of the sourcecites [41] van Eekelen, J.A. et al. Expression pattern of the stem cell leukaemia gene in the CNS of the embryonic and adult mouse. Neuroscience 122, 421–436 (2003). source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“FAST-QC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 52 quality checks were done to determine high quality base pairs,”
What the sources say
- Not matchedcites [52] Babraham Bioinformatics. FastQC: a quality control tool for high throughput sequence data http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ (accessed 5 February 2017).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data confirm that human microglia are immunocompetent and phagocytic cells of the CNS that express a wide range of immune receptors and ligands, equipped to respond to a wide variety of pathogen- and damage-associated molecules.”
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The 39 selected samples are representative of normal human cortical microglia.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Cells were sorted on the basis of CD11b high CD45 int expression and negative staining for DAPI or the LIVE/DEAD Fixable Red Dead Cell stain (L23102, ThermoFisher Scientific) and collected in RNAlater (Qiagen, Germany).”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The overlap in genes differentially expressed during aging between human and mouse is very limited, suggesting that the microglia of physiologically aged mice do not recapitulate the effect of aging on human microglia.”
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Age-associated gene expression changes in the donor microglia are attributable to aging rather than to cause of death, comorbidity or other donor characteristics.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The leptomeninges were removed to avoid potential contamination by meningeal macrophages.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“RUNX1 activates the transcription of SPI-1 (ref. 43), a bona fide microglial transcription factor.”
What the sources say
- Not checked — no full text of the sourcecites [43] Huang, G. et al. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat. Genet. 40, 51–60 (2008). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“RNA quality was checked with the Experion RNA HighSens Analysis Kit (Bio-Rad, USA) and RNA Screen Tape (Agilent Technologies, USA).”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“IRF8 is necessary for microglial genesis, along with SPI-1 (ref. 2),”
What the sources say
- Not checked — no full text of the sourcecites [2] Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273–280 (2013). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data corroborate the notion that human microglia are potent antigen-presenting cells and are able to interact with CD4 and CD8 T-helper cell subsets.”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Integrin-SYK signaling is also responsible for negatively regulating Toll-like receptor (TLR) signaling and the NFκ B pathway by promoting the degradation of MYD88 (ref. 21).”
What the sources say
- Not checked — no full text of the sourcecites [21] Kondo, T., Kawai, T. & Akira, S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 33, 449–458 (2012). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No statistical methods were used to predetermine samples sizes; as many samples as possible were collected in the available time period.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Two of these transcription factors are essential for microglial ontogeny: SPI-1 (PU.1) and IRF8 (ref. 2).”
What the sources say
- Not checked — no full text of the sourcecites [2] Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273–280 (2013). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“IFI16 may support the relative microglial quiescence that is observed under normal conditions.”
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Rests on an assumption: The CXCR-CD74 pathway is dependent on extracellular signals.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our finding that human microglia express many SIGLECs highlights their importance and the specialization of microglia for the maintenance of a homeostatic microenvironment.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The 39 selected samples are representative of normal human cortical microglia.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The expression values were adjusted according to the surrogate variables identified by sva using the function removeBatchEffect from the limma package.”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Per sample, on average 17.6 million uniquely mapped reads were generated, ranging between 6 and 61.1 million.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The second comparison was performed as a multivariate linear model that included gender as a binary variable, while age, PMD and the surrogate variables calculated with sva were used as quantitative variables.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Samples were not randomized; all collected samples were RNA-sequenced or used for protein sample preparation.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Data collection and analysis were not performed blind to the conditions of the experiments and no data points were excluded from the analyses.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Vimentin was used as in internal standard for membrane normalization.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The distribution of the RNA-seq data was as expected for sequencing data; no particular testing was performed.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper relies on this without support.
The pathologies that led to the donors' deaths did not substantially alter the microglial transcriptome, so the profiles approximate physiological human microglia.
“Nonetheless, all donors suffered from a range of pathologies ultimately leading to their death, potentially affecting the microglial gene expression profile.”
The paper relies on this without support.
Age-associated gene expression changes in the donor microglia are attributable to aging rather than to cause of death, comorbidity or other donor characteristics.
“The ages of our donors ranged between 34 and 102 years, allowing us to examine changes in microglial gene expression that occurred during aging.”
The paper relies on this without support.
The 39 selected samples are representative of normal human cortical microglia.
“Ultimately, 39 samples from donors with a history of normal cognitive function and no apparent neuropathological abnormalities with sufficient levels of high-quality RNA were selected for RNA sequencing.”
The paper relies on this without support.
Cross-species comparisons using different RNA quantification technologies (3' QuantSeq, microarrays and RNA-seq) are valid for assessing overlap.
“Even though these mouse expression data were generated using very different technologies (3 ′ -end polyadenylated RNA sequencing, microarrays and RNA-seq, respectively), we observed an extensive overlap with human microglial data.”
The paper relies on this without support.
The published human CD45+ cell population from Zhang et al. is comparable to microglia for the overlap analysis.
“We compared our human microglial expression profile to a published profile of the human CD45 + microglial cell population, isolated using immunopanning from temporal lobe cortex tissue obtained during tumor or epilepsy surgery 15 .”
The paper relies on this without support.
The CXCR-CD74 pathway is dependent on extracellular signals.
“this pathway is dependent on extracellular signals,”
The paper relies on this without support.
Actin (dis)assembly is essential for cellular motility and migration.
“As actin (dis)assembly is essential for cellular motility and migration,”
The paper relies on this without support.
Binding of chemoattractant ligands to their respective receptors on myeloid cells induces these cells to move toward injury sites, apoptotic cells or invading microorganisms.
“Binding of chemoattractant ligands to their respective receptors on myeloid cells induces these cells to move toward injury sites, apoptotic cells or invading microorganisms.”
The paper relies on this without support.
Movement of fine microglial processes to sense the environment and initiate chemotaxis is primarily governed through these receptors.
“Movement of fine microglial processes to sense the environment and initiate chemotaxis is primarily governed through these receptors,”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although some studies have identified selected overlaps in expression changes between AD mouse models and human brains (Bennett et al., 2018; Castillo et al., 2017; Mostafavi et al., 2018; Neuner et al., 2019; Rojo et al., 2017), other studies have questioned the overall degree of conservation (Burns et al., 2015; Galatro et al., 2017; Hargis and Blalock, 2017).”
From Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models (2020) · cites this paper as Galatro et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal microglia are often inaccessible to real-time imaging, and cannot fully reflect human biology.15–17”
From Tubular human brain organoids to model microglia-mediated neuroinflammation (2021) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent transcriptome-wide studies of bulk ex vivo human microglia have consistently suggested that microglia change with age and have transcriptomes that are enriched for disease-related genes3–5.”
From Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease (2020) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, microglial functions vary across different ages, disease pathologies, and between sexes10–16.”
From Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The number of genes that overlapped between the datasets was small, but significant (upregulated genes OR = 23.4; P < 1 × 10−16, downregulated genes OR = 5.97; P < 1 × 10−16; Fisher’s Exact test; Fig. 3e).”
From Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies (2022) · cites this paper as [16]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While APOE is upregulated in human microglia in AD, the mouse DAM phenotype is absent or only partially overlaps, highlighting species differences between human and mouse and the importance of studying APOE4 in human systems (Galatro et al., 2017; Li et al., 2021; Srinivasan et al., 2020; Zhou et al., 2020).”
From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Galatro et al., 2017
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, we found age-related changes in genes involved in a wide range of inflammatory responses, in line with previous results in aging in microglia16,26,62 and peripheral blood39.”
From Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies (2022) · cites this paper as [16]
In the citing paper
“Recent transcriptomic analysis of human cortical microglia implicates that genes involved in actin assembly normally required to mediate morphogenic changes in microglia are downregulated during aging. As dynamic filamentous actin (F-actin) assembly is essential to microglia morphogenesis, migration, and Aβ uptake/clearance, these results suggest that fundamental microglial functions are impaired”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [523]
In the citing paper
“There was surprisingly limited overlap, however, in microglial genes regulated by aging in human versus mouse (Grabert et al., 2016; Galatro et al., 2017)”
From Microglia in Alzheimer’s disease (2018) · cites this paper as Galatro et al., 2017
In the citing paper
“A growing number of non-viral diseases are characterized by the presence of a similar IFN transcriptional signature (Mostafavi et al. , 2016) evident within the microglial transcriptome itself as upregulated interferon signalling gene sets in cells isolated from both an Alzheimer's disease-like model of neurodegeneration as well as ageing humans (Galatro et al. , 2017; Mathys et al. , 2017).”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as Galatro et al., 2017
In the citing paper
“a number of important studies have compared gene expression in microglia from mice and humans, and while they have shown a significant overlap between the transcriptomes of the two species, they have also seen a number of genes are expressed selectively more abundantly in human microglia”
From Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk (2019) · cites this paper as Galatro et al., 2017
In the citing paper
“there is a substantial overlap in human orthologues expressed by the mouse amyloid-responsive microglia and the transcripts expressed abundantly by human microglia from Galatro et al. (2017) and Gosselin et al. (2017).”
From Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk (2019) · cites this paper as Galatro et al., 2017
In the citing paper
“Our four putative risk genes, OAS1, LAPTM5, LILRB4 and ITGAM/CD11b are expressed abundantly in the human microglia (Galatro et al., 2017; Gosselin et al., 2017)”
From Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk (2019) · cites this paper as Galatro et al., 2017
In the citing paper
“Just as DAM genes induced in neurodegenerative mouse models overlap with those induced by natural aging (Friedman et al., 2018; Holtman et al., 2015), so do many HAM genes induced in human AD tissues (Figure 5A), though the genes involved are distinct between species (Galatro etal.,2017).”
From Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation (2020) · cites this paper as Galatro et al., 2017
In the citing paper
“The few DE genes between 5xFAD/TREM2 and 5xFAD were highly enriched in microglia and immune cell activation annotations (Galatro et al., 2017).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Galatro et al., 2017
In the citing paper
“The top enrichment terms for TD1 genes are “Upregulated in damage associated microglia” (p = 2.29E-23; Keren-Shaul et al., 2017), “top human microglia-specific genes” (p = 2.15E-16; Galatro et al., 2017), “Autophagy lysosome” (p = 4.90E-09), “genes upregulated with age in hippocampus” (p = 2.89E-08), and “immune system process” (p = 0.000142).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Galatro et al., 2017
In the citing paper
“Transcriptome analysis of aged human microglia reveal specific genes influenced by aging [52-54].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [52]
In the citing paper
“and that microglial gene expression changes with aging (110–112).”
From The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (2019) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Postmortem-delay range differs
MinorThe results state that microglia were isolated after a 6- to 24-hour postmortem delay, while the discussion describes the assessed range as 4 to 24 hours.
“Microglial isolations were performed within a 6- to 24-h postmortem delay (PMD) from donors without diagnosed brain diseases.”
“Our data indicate that a PMD between 4 and 24 h had very little influence on the microglial gene expression profile.”
Percentile-comparison formula does not define the reported difference
MinorThe results define the change in percentile by subtracting the two percentiles. The methods instead specify one minus the absolute difference, which is a different quantity.
“the respective percentiles of each gene in our human data set and the CD45 + data set were subtracted to give the change in percentile ( ∆ percentile)”
“The percentiles the human genes and the other data sets were pairwise compared using the formula 1 - absolute (human percentile - mouse percentile).”
CoRegNet results assigned to different figures
MinorThe results and Figure 3 caption place the predicted transcriptional regulators in Figure 3. The methods say those regulators and their targets are shown in Figure 2.
“The Bioconductor package CoRegNet identified 12 microglia-specific transcriptional regulators of the human core genes ( Fig. 3a ).”
“The most influential transcription factors, their interactions and their putative target genes are shown in Figure 2 .”
Protein-array donor pooling differs
MinorThe results and figure caption describe two pooled samples containing three and four donors, respectively. The methods instead specify four donors per sample.
“Parietal cortical microglia were isolated from seven autopsy tissue samples using FACS and pooled in two samples of three and four donors, respectively.”
“FACS-sorted microglia (200,000-400,000 per donor, 4 donors per sample) were collected in lysis buffer with protease inhibitors.”
CD45+ comparison cites two different Zhang references
MinorThe figure caption attributes the CD45+ comparison to Zhang et al. reference 6, while the results attribute that comparison to reference 15. The paper's reference list identifies these as different Zhang publications.
“( n = 3 samples, Zhang et al. 6 )”
“We compared our human microglial expression profile to a published profile of the human CD45 + microglial cell population, isolated using immunopanning from temporal lobe cortex tissue obtained during tumor or epilepsy surgery 15 .”
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
affy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · cited 1×
“To minimize the reported effect of brain region on microglial gene expression 6,23,24 , only cortical microglia were included in our comparisons.”
ResultMapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Durinck, S., Spellman, P. T., Birney, E., & Huber, W. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,226
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–777 of 777
Additional file 4 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26704716
Additional file 8 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26704728
Additional file 3 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26704713
Additional file 1 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25583880
Peng, D., Li, J., Deng, Y., Zhu, X., Zhao, L., Zhang, Y., Li, Z., Ou, S., Li, S., & Jiang, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13250655
Additional file 1 of Microglial amyloid beta clearance is driven by PIEZO1 channels
Jäntti, H., Sitnikova, V., Ishchenko, Y., Shakirzyanova, A., Giudice, L., Ugidos, I. F., Gómez‐Budia, M., Korvenlaita, N., Ohtonen, S., Belaya, I., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080821
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681788
Sudwarts, A., Ramesha, S., Gao, T., Ponnusamy, M., Wang, S., Hansen, M. T., Kozlova, A., Bitarafan, S., Kumar, P., Beaulieu‐Abdelahad, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19728388
Additional file 1 of Distinct sex-specific DNA methylation differences in Alzheimer’s disease
C. Silva, T., Zhang, W., Young, J. I., Gomez, L., Schmidt, M. A., Varma, A., Chen, X. S., Martin, E. R., & Wang, L. (2022) · Figshare · doi:10.6084/m9.figshare.21129953
Additional file 1 of Evolutionary conservation and divergence of the human brain transcriptome
Pembroke, W. G., Hartl, C., & Geschwind, D. H. (2021) · Figshare · doi:10.6084/m9.figshare.13667952
Additional file 11 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26704737
Additional file 9 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26704731
Additional file 1 of Epigenetic regulation of innate immune memory in microglia
Zhang, X., Kracht, L., Lerário, A. M., Dubbelaar, M. L., Brouwer, N., Wesseling, E. M., Boddeke, E., Eggen, B. J. L., & Kooistra, S. M. (2022) · Figshare · doi:10.6084/m9.figshare.19768078
Self-citationAdditional file 1 of A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
Batenburg, K. L., Sestito, C., Cornelissen‐Steijger, P., van Weering, J. R. T., Price, L., Heine, V. M., & Scheper, W. (2024) · Figshare · doi:10.6084/m9.figshare.26570704
Sudwarts, A., Ramesha, S., Gao, T., Ponnusamy, M., Wang, S., Hansen, M. T., Kozlova, A., Bitarafan, S., Kumar, P., Beaulieu‐Abdelahad, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19728385
Additional file 2 of A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
Batenburg, K. L., Sestito, C., Cornelissen‐Steijger, P., van Weering, J. R. T., Price, L., Heine, V. M., & Scheper, W. (2024) · Figshare · doi:10.6084/m9.figshare.26570707
Miedema, A., Gerrits, E., Brouwer, N., Jiang, Q., Kracht, L., Meijer, M., Nutma, E., Peferoen-Baert, R. M. B., Pijnacker, A. T. E., Wesseling, E. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19090719
Self-citationLiu, Y., Peng, L., Chen, J., Chen, L., Wu, Y., Cheng, M., Chen, M., Ye, X., & Jin, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22606937
Miedema, A., Gerrits, E., Brouwer, N., Jiang, Q., Kracht, L., Meijer, M., Nutma, E., Peferoen-Baert, R. M. B., Pijnacker, A. T. E., Wesseling, E. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19090713
Self-citationMiedema, A., Gerrits, E., Brouwer, N., Jiang, Q., Kracht, L., Meijer, M., Nutma, E., Peferoen-Baert, R. M. B., Pijnacker, A. T. E., Wesseling, E. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19090707
Self-citationAdditional file 2 of Epigenetic regulation of innate immune memory in microglia
Zhang, X., Kracht, L., Lerário, A. M., Dubbelaar, M. L., Brouwer, N., Wesseling, E. M., Boddeke, E., Eggen, B. J. L., & Kooistra, S. M. (2022) · Figshare · doi:10.6084/m9.figshare.19768081
Self-citationNatunen, T., Martiskainen, H., Marttinen, M., Gabbouj, S., Koivisto, H., Kemppainen, S., Kaipainen, S., Takalo, M., Svobodová, H., Leppänen, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13213043
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.25237386
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681785
Additional file 3 of Epigenetic regulation of innate immune memory in microglia
Zhang, X., Kracht, L., Lerário, A. M., Dubbelaar, M. L., Brouwer, N., Wesseling, E. M., Boddeke, E., Eggen, B. J. L., & Kooistra, S. M. (2022) · Figshare · doi:10.6084/m9.figshare.19768084
Self-citationCuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681791
Additional file 5 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26704719
Additional file 13 of Evolutionary conservation and divergence of the human brain transcriptome
Pembroke, W. G., Hartl, C., & Geschwind, D. H. (2021) · Figshare · doi:10.6084/m9.figshare.13667949
Additional file 4 of Epigenetic regulation of innate immune memory in microglia
Zhang, X., Kracht, L., Lerário, A. M., Dubbelaar, M. L., Brouwer, N., Wesseling, E. M., Boddeke, E., Eggen, B. J. L., & Kooistra, S. M. (2022) · Figshare · doi:10.6084/m9.figshare.19768087
Self-citationSudwarts, A., Ramesha, S., Gao, T., Ponnusamy, M., Wang, S., Hansen, M. T., Kozlova, A., Bitarafan, S., Kumar, P., Beaulieu‐Abdelahad, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19728379
Additional file 7 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26704725
Sudwarts, A., Ramesha, S., Gao, T., Ponnusamy, M., Wang, S., Hansen, M. T., Kozlova, A., Bitarafan, S., Kumar, P., Beaulieu‐Abdelahad, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19728370
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681779
Additional file 2 of An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25584031
Frieß, L., Cheray, M., Keane, L., Grabert, K., & Joseph, B. (2021) · Figshare · doi:10.6084/m9.figshare.14728529
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681782
Sudwarts, A., Ramesha, S., Gao, T., Ponnusamy, M., Wang, S., Hansen, M. T., Kozlova, A., Bitarafan, S., Kumar, P., Beaulieu‐Abdelahad, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19728367
Kamzina, A. S., Leinenweber, K. E., Ecca, F., Aldabergenova, A., & Huentelman, M. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.25.706648
Promprom, W., Chatan, W., Homwutthiwong, K., Apaijit, K., Cheepsunthorn, P., & Mairuae, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062809
Implication des macrophages périphériques dans la Sclérose latérale Amyotrophique
Chiot, A. (2018) · theses.fr (ABES) · doi:10.70675/e3d90f5az237az4722zbff2z9c99590e826b
Characterization of the FGFR3 regulatory network in bladder cancer
Moreno-Vega, A. I. (2020) · theses.fr (ABES) · doi:10.70675/6eeb1e56z5a60z42bcz9a00z1bf9509f7449
Chataigner, M. (2021) · theses.fr (ABES) · doi:10.70675/a4317690zc4c8z4ba6za738zd457c6bb9b74
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Investigation of regulatory plasma cells in health and disease
Bui, T. C. (2022) · theses.fr (ABES) · doi:10.70675/65ea40a7zbe2dz4f33z969bz1fa9a07e0174
Yildirim-Balatan, C. (2021) · theses.fr (ABES) · doi:10.70675/3372ff2ez69a6z4970z881bze4dfe0a15571
Kozlov, S. O., Schmidt, E., Theis, H., Domenico, E. D., Beyer, M., & Halle, A. (2026) · Glia · doi:10.1002/glia.70144 · Cited by 1
Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies
Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b
Barresi, M., Prasad, R. R., Quigley, A., Gressèns, P., Tolcos, M., & Fleiss, B. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.03.015
Xu, Y., Liang, W., Tang, Z., Lu, F., Xia, L., Xie, H., Zhong, M., & Li, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116773
Zhao, Y., Conghui, L., Yv, K., Wang, N., & Li, Z. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261452242 · Cited by 1
Expression of GPR34 in microglia remains stable in human Alzheimer’s disease
Seiffer, S., Rotter, J., Brendler, J., Ricken, A. M., Detzer, Z., Braune, M., Schöneberg, T., Schulz, A., Winter, K., & Bechmann, I. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03035-0
Smoking accelerates immunosenescence in multiple sclerosis
Khan, M., Uawithya, E., Mytych, J. S., Muwenda, I., Reidy, M., Axtell, R. C., & Mao‐Draayer, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1840928
Age-associated microglial heterogeneity includes emergence of mobile microglial states
Subhramanian, S., Bocharova, O. V., Mychko, O., Makarava, N., & Baskakov, I. V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1847223
Microglia in Alzheimer’s disease: Insights into disease progression and therapy
Saini, V., Mukherjee, S., Vora, C., Jindal, H., & Jha, H. C. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.06.004
Distinct Transposable Element Transcript Patterns in Microglia Across Aging and Alzheimer's Disease
Grant, R. A., Doser, R. L., & LaRocca, T. J. (2026) · Aging Cell · doi:10.1111/acel.70653
Şimşekçi, U., & Cesaretli, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1882211
Nikolova, M. T., Freitag, K., Okamoto, R., Catellani, A., Hinke, J., Luginbühl, N., Lin, H., Kaindl, J., He, Z., Wahle, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.25.754357
Pinto, I. M., Beça, P., Correia, M., Moreira, J. T., Galvão, J., Portugal, C. C., Relvas, J. B., & Socodato, R. (2026) · Targetome · doi:10.48130/targetome-0026-0035
Yang, Y., Dai, C., Xu, Z., Zhuo, L., Xiang, K., Lin, X., Sun, J., Liu, J., & Tong, Q. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01069
van Bruggen, V. L. E., Claassen, S. J. C. M., Klein, L., Bokobza, C., Hua, J., Marvillet, T., Zandbergen, M. M. E., van Gorp, C., Caimant, F., van der Molen, R. G., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101359
Exploring the role of infectious pathogens in Alzheimer’s disease neuroinflammation
Vaiasicca, S., Mangiaterra, G., Citterio, B., Piccioni, G., Orlando, F., Giorgetti, B., Cianfruglia, L., Giacconi, R., Fumarola, S., Cardelli, M., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1919289
Dysfunction of lipid metabolism and lysosomal capacity: at the core of microglial aging?
Šimončičová, E., & Tremblay, M. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1884230
Wong, H. T., Gleason, C., Boylan, A., Adler, M. J., Kosoy, R., Fullard, J. F., Levendosky, E., Hoffman, G. E., Molina, H., Roussos, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.25.754430
Cai, D., Ke, X., Luo, F., Li, Y., Cai, H., 祝继洪, Chen, Y., & Chen, G. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2026-0136
Gogu, M.-R., Costăchescu, I., Stanciu, G. D., Tamba, B.-I., Ciorpac, M., & Gorgan, L. (2026) · Pharmaceuticals · doi:10.3390/ph19101603
Translational modelling of human microglia from cultures to chimeras
Lee, J., & Yoo, Y. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01866-1
SHIP1 regulates TREM2 signalling and macrophage functions in a hiPSC ‐derived model
Martin, K. S., Obst, J., Ibarra, S., Murphy, E. J., Gospodinova, K., & Mead, E. (2026) · FEBS Journal · doi:10.1111/febs.70752
Khan, G. N., Gul, S., & Lee, S. H. (2026) · Indus journal of bioscience research. · doi:10.70749/ijbr.v4i4.2971
Salari, A., Yazdani, M., Sharifipasandi, M., Akbari, M., Saadati, P., Sahabjo, A., Shahsavari, M. H., Mousavi, S. M., Tabatabayi, M. A., Estahri, B., et al. (2026) · Discover Immunity. · doi:10.1007/s44368-026-00037-8
Tang, Y. M., Lo, R., Thiry, L., Fiorini, M. R., Farhan, S., Pandolfo, M., & Stifani, S. (2026) · Research Square · doi:10.21203/rs.3.rs-11037120/v1
Skóra, B., & Szychowski, K. A. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.10.045
Lakshmi, S. M., Singh, V., Vanangamudi, M., Taj, T., Shahin, H., Nath, R., Dutta, G., Avvari, S. K., Sridhar, S. B., Panigrahy, U. P., et al. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70718
Gommerman, J. L., Akassoglou, K., Baranzini, S. E., Becher, B., Brilot, F., Castelo‐Branco, G., Dunn, S. E., Faiz, M., Flügel, A., Ghasemlou, N., et al. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01272-1
Human brain cellular xenografts in neuroimmunology and beyond
Fattorelli, N., Martínez‐Muriana, A., Perry, V. H., & Mancuso, R. (2026) · Immunity · doi:10.1016/j.immuni.2026.09.024
Metadata
- Authors
- Galatro, T. F., Holtman, I. R., Lerario, A. M., Vainchtein, I. D., Brouwer, N., Sola, P. R., Veras, M. M., Pereira, T. F., Leite, R. E. P., Möller, T., Wes, P. D., Sogayar, M. C., Laman, J. D., den Dunnen, W., Pasqualucci, C. A., Oba-Shinjo, S. M., Boddeke, E. W. G. M., Marie, S. K. N., & Eggen, B. J. L.
- Affiliations
- University Medical Center Groningen (NL)
- Universidade de São Paulo (BR)
- Lundbeck (United States) (US)
- Corresponding author
- Eggen, Bart J L
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2017-07-03
- Volume
- 20
- Issue
- 8
- Pages
- 1162-1171
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2729351500
- Cited by
- 741
- References
- 62
- Citations by year
- 2026: 65 · 2025: 58 · 2024: 99 · 2023: 65 · 2022: 108 · 2021: 105 · 2020: 92 · 2019: 71 · 2018: 65 · 2017: 11
- FWCI
- 32.12
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- microglia, cortical microglia, microglial gene expression, brain aging, human-mouse comparison, age-related gene expression, Fc gamma receptor, Siglec receptors, IFI16, TAL1, CX3CR1, P2Y12 receptor, CD11b, cell adhesion, actin cytoskeleton, neurodegeneration, parietal cortex
- MeSH terms
- Aging, Axons, Brain, Cell Cycle, Humans, Gene Expression, Microglia, Gene Expression Profiling, CD11b Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review